Published on 02/12/2025

Test Protocols for Models: Unit, Integration, and System

In the ever-evolving landscape of pharmaceutical research and clinical operations, the advent of Artificial Intelligence (AI) and Machine Learning (ML) has introduced a paradigm shift in data analytics. Proper validation of AI/ML models that are employed under Good Automated Manufacturing Practice (GxP) guidelines is essential. This article serves as a step-by-step tutorial guide on various test protocols tailored for unit, integration, and system models, focusing on essential elements such as verification, documentation, and compliance with regulatory standards, particularly under US FDA, EMA, and MHRA mandates.

Step 1: Define the Intended Use and Risk Assessment

Understanding the intended use of the model is paramount. The intended use defines the purpose for which the model is created, and it plays a crucial role in framing the validation strategy.

• Identify the intended use: Determine what the model is expected to accomplish. This involves detailing the clinical objectives, performance requirements, and the target population.
• Risk assessment: Conduct a comprehensive risk assessment to identify potential impacts on patient safety and data integrity. Utilize tools like Failure Mode Effects Analysis (FMEA) to evaluate risks inherent in the model’s operation.
• Document outcomes: Clearly document all results from the intended use and risk assessment procedures. This will be critical for regulatory review and in establishing compliance with guidelines such as FDA’s AI/ML guidance.

Step 2: Data Readiness and Curation

Data readiness is integral to AI/ML model validation. Incomplete or poorly curated data can lead to erroneous model predictions, affecting clinical outcomes.

• Data collection: Gather all datasets that will feed the model. This includes clinical trial data, historical patient records, and other relevant sources.
• Data validation: Ensure the data is accurate, complete, and appropriate for the model’s intended use. Perform sanity checks, outlier analysis, and validation against existing domain knowledge.
• Data curation: Document data cleaning and preprocessing activities, such as handling missing values, normalization, and feature selection. Maintain an auditable trail of data transformations complying with regulations like 21 CFR Part 11.

Step 3: Model Verification and Validation

Verification and validation (V&V) are critical processes that ensure the AI/ML model functions accurately and reliably in the intended environment.

• Model verification: Verify that the model was built correctly according to algorithm specifications. This can involve reviewing model training processes, input data, and algorithm equations.
• Model validation: Validate the model against external benchmarks or benchmarks established during training. This involves comparing model outputs with established clinical outcomes to ascertain predictive reliability.
• Documentation: Keep comprehensive records of the V&V process, including protocols, results, and any deviations from the expected pathway. This documentation is vital for audits by regulatory bodies like EMA and MHRA.

Step 4: Bias and Fairness Testing

In light of increasing regulatory scrutiny on AI/ML models, bias and fairness testing is an imperative part of the validation process. Ensuring that predictions are unbiased and equitable across all demographics is crucial.

• Understand bias: Recognize potential sources of bias in training datasets, algorithms, or during deployment stages that may affect outcomes.
• Testing methodologies: Employ statistical tests and techniques to evaluate the model’s performance across different demographic groups to ensure equitable outcomes. Techniques may include stratified sampling and cross-validation.
• Document findings: Thoroughly document the results of bias and fairness analyses. Establish procedures for continuous monitoring to ensure compliance with both internal standards and those dictated by guidelines from organizations such as WHO.

Step 5: Drift Monitoring and Re-validation

Once an AI/ML model is deployed, drift in data patterns may occur, necessitating ongoing monitoring and re-validation to maintain model effectiveness.

• Establish drift metrics: Define the parameters that will be monitored to detect performance drift. Examples include changes in input feature distributions or alterations in model prediction accuracy.
• Continuous re-validation: Implement a protocol for periodic re-validation of the model to assess its predictive performance against newly acquired data.
• Report monitoring results: Ensure that all results from drift monitoring and re-validation efforts are documented, contributing to an effective audit trail.

Step 6: Explainability and Transparency (XAI)

Understanding how AI models arrive at decisions is critical, not only for building trust with healthcare professionals but also for regulatory compliance.

• Incorporate Explainable AI (XAI): Utilize explainability frameworks that outline how results are produced and provide insights into the model decision-making process.
• Documentation of features: Maintain documentation detailing model features and their respective influences on predictions.
• Engagement with stakeholders: Foster discussions with stakeholders—clinical teams and regulatory bodies—about explainability aspects to ensure outputs align with practical relevance.

Step 7: Documentation and Audit Trails

Comprehensive documentation of every aspect of AI/ML validation is a regulatory requirement and critical to maintaining compliance.

• Maintain a validation plan: Create a detailed validation plan outlining the necessary steps involved in testing and validating the AI/ML model.
• Audit trails: Ensure the availability of electronic and physical audit trails that track all model revisions, data modifications, and validation results as per GAMP 5 recommendations.
• Review and update documentation: Regularly review all documentation and update it whenever pertinent changes are made to the model or its operating environment.

Step 8: AI Governance and Security

Ensuring that AI/ML models adhere to security and governance protocols is paramount in a regulated environment such as pharmaceuticals.

• Establish governance frameworks: Develop governance structures for overseeing the AI model lifecycle, including development, deployment, monitoring, and sunset plans.
• Implement security measures: Incorporate cybersecurity controls to protect model integrity and data confidentiality, following relevant standards such as Annex 11.
• Periodic audits: Conduct regular audits to verify compliance with established governance and security protocols. Involve cross-functional teams to garner diverse insights during audit processes.

Conclusion

In conclusion, validating AI/ML models for pharmaceutical applications calls for adherence to rigorous verification processes, comprehensive documentation, and compliance with prevailing regulatory standards. By following the outlined steps—defining intended use, ensuring data readiness, conducting thorough verification and validation, addressing bias, monitoring drift, ensuring explainability, maintaining robust documentation, and focusing on governance—pharmaceutical professionals can successfully safeguard their models against non-compliance and enhance their reliability in clinical decision-making processes. Continuous engagement with evolving regulatory guidance is essential as the field of AI/ML expands.